Streetbeat News

Products Services

KOPN

Kopin Corporation and Wilcox Industries have partnered to develop a Modular Dismounted Soldier System, which includes integrated day and night heads-up display optical solutions.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 8:02 pm

ABVX

Abivax SA (NASDAQ: ABVX) provided an update on its Phase 3 ABTECT trial for obefazimod in ulcerative colitis, which is on track to complete enrollment in early Q1 2025. The company expects top-line results in early Q2 2025 and has sufficient cash to fund operations through Q4 2025. Leadership changes include Sylvie Grégoire as Chair of the Board, Dr. Fabio Cataldi as Chief Medical Officer, and Dr. David Zhang as Chief Strategy Officer.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 8:01 pm

AMD

Deep-pocketed investors have shown significant interest in Advanced Micro Devices (NASDAQ:AMD) through a surge in options activity. Benzinga's options scanner highlighted 127 extraordinary options activities, with a mix of bullish and bearish sentiments. Analysts have set an average price target of $211.25 for AMD, with the stock currently trading at $179.6.

Portfolio Pulse from Benzinga Insights

July 15, 2024 | 8:01 pm

GM

In a recent CNBC interview, GM CEO Mary Barra announced that the company will not meet its target of producing 1 million electric vehicles (EVs) by the end of the year. This shortfall is attributed to supply chain issues and slower-than-expected production ramp-up.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 7:59 pm

AFRM

Affirm Holdings, Inc. (NASDAQ:AFRM) shares are moving higher due to a new partnership with RONA inc., allowing RONA customers to use Affirm's Buy Now, Pay Later service for online purchases. This partnership aligns with both companies' strategies to enhance customer convenience and adapt to evolving shopping habits.

Portfolio Pulse from Vaishali Prayag

July 15, 2024 | 7:58 pm

NVAX

Novavax, Inc. (NASDAQ: NVAX) shares are rising after the company filed for authorization with Health Canada for its updated 2024-2025 protein-based COVID-19 vaccine. The vaccine targets the JN.1 variant and has shown broad neutralization responses. Novavax has also submitted filings with the U.S. FDA and EMA. The stock saw a 15.6% increase, trading at $15.17.

Portfolio Pulse from Vaishali Prayag

July 15, 2024 | 7:55 pm

SOFI

Shares of SoFi Technologies, Inc. (NASDAQ:SOFI) surged by 5.95% to $7.38 amid optimism on Fed policy and political developments related to former President Trump. The market is reacting to potential benefits for financial institutions from Trump's stance on student loan forgiveness and Project 2025 proposals.

Portfolio Pulse from Vaishali Prayag

July 15, 2024 | 7:28 pm

ETHUSD

MATICUSD

MGM

USDCUSD

An assassination attempt on former President Donald Trump has significantly impacted the betting odds for the 2024 presidential election. Trump now has the shortest odds to win, with sportsbooks like BetMGM listing him at -250. The Democratic Party faces internal challenges, with Biden's odds fluctuating and Harris's approval ratings lower than Biden's.

Portfolio Pulse from Chris Katje

July 15, 2024 | 7:19 pm

ETHUSD

SOLUSD

Solana (SOL) is up 7% and could reach 50% of Ethereum's (ETH) valuation, driven by bullish sentiment and potential ETF approval. Increased on-chain activity and high liquidity make SOL a strong asset. Non-vote transactions on Solana hit an all-time high, and open interest surged to $2.14 billion.

Portfolio Pulse from Khyathi Dalal

July 15, 2024 | 7:16 pm

ZLAB

Zai Lab Limited announced a publication in 'Cell' highlighting the effects of niraparib on ovarian cancer microenvironment stratified by HRD. The study suggests that combining niraparib with ZL-1218, an investigational CCR8 antibody, may decrease tumor burden, offering synergistic potential for improving treatment efficacy in HRD tumors.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 6:57 pm